Advancing Individualized Medicine
The Cluster for Individualized Immune Intervention (Ci3) e.V. is a non-profit organization with the aim of promoting the advancement of personalized medicine and individualized immunotherapies for the treatment of serious diseases such as cancer. By facilitating collaboration between academia, small and medium-sized enterprises, large corporations, regulators and the public, we are contributing to the development and establishment of innovative solutions in the healthcare sector.
Ci3 Cluster under new management08/05/2020
BioNTech and Pfizer announce approval from Paul-Ehrlich-Institute to commence first clinical trial in Germany for COVID-19 vaccine candidates22/04/2020
Open Call for Project Proposals in DIGI-B-CUBE14/04/2020
Online dialogue of National Decade Against Cancer starts15/11/2019